<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/themes/root/assets/xsl/rss.xsl"?>
<rss version="2.0" xmlns:opensearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/">
  <channel>
    <title>Resultados para First Line</title>
    <description>Mostrando 1 - 50 Resultados de 392137</description>
    <generator>Laminas_Feed_Writer 2 (https://getlaminas.org)</generator>
    <link>https://descubridor.academia.cl/EIT/Search?limit=50&amp;lookfor=First+Line&amp;type=TX&amp;lng=es</link>
    <opensearch:totalResults>392137</opensearch:totalResults>
    <opensearch:startIndex>0</opensearch:startIndex>
    <opensearch:itemsPerPage>50</opensearch:itemsPerPage>
    <opensearch:Query role="request" searchTerms="First%20Line" startIndex="0"/>
    <atom:link rel="first" type="application/rss+xml" title="Ir a la Primera Página" href="https://descubridor.academia.cl/EIT/Search?limit=50&amp;view=rss&amp;lookfor=First+Line&amp;type=TX&amp;lng=es"/>
    <atom:link rel="next" type="application/rss+xml" title="Ir a la Siguiente Página" href="https://descubridor.academia.cl/EIT/Search?limit=50&amp;view=rss&amp;lookfor=First+Line&amp;type=TX&amp;lng=es&amp;page=2"/>
    <atom:link rel="last" type="application/rss+xml" title="Ir a la Ultima Página" href="https://descubridor.academia.cl/EIT/Search?limit=50&amp;view=rss&amp;lookfor=First+Line&amp;type=TX&amp;lng=es&amp;page=7843"/>
    <atom:link rel="self" type="application/rss+xml" href="https://descubridor.academia.cl/EIT/Search?limit=50&amp;view=rss&amp;lookfor=First+Line&amp;type=TX&amp;lng=es"/>
    <item>
      <title>Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis.</title>
      <pubDate>Thu, 01 Jan 2026 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/196621289</link>
      <guid>https://descubridor.academia.cl/EITRecord/196621289</guid>
      <author>Kajiura, Shinya</author>
      <dc:format>Journal Article</dc:format>
      <dc:date>2026-08-01</dc:date>
      <dc:creator>Kajiura, Shinya</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Facility-Level Availability of Japanese Society of Medical Oncology Specialists and Recorded First-Line Treatment-Process Duration in Pancreatic Cancer: A Nationwide Center for Cancer Genomics and Advanced Therapeutics Registry Analysis.</title>
      <pubDate>Thu, 01 Jan 2026 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/195807425</link>
      <guid>https://descubridor.academia.cl/EITRecord/195807425</guid>
      <author>Kajiura, Shinya</author>
      <dc:format>Journal Article</dc:format>
      <dc:date>2026-07-01</dc:date>
      <dc:creator>Kajiura, Shinya</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Cost-Effectiveness of First-Line Immunochemotherapy Versus BRAF Plus MEK Inhibitors in BRAF V600E -Mutated Metastatic Lung Cancer.</title>
      <pubDate>Thu, 01 Jan 2026 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/195807416</link>
      <guid>https://descubridor.academia.cl/EITRecord/195807416</guid>
      <author>Chen, Chian-Wei</author>
      <dc:format>Journal Article</dc:format>
      <dc:date>2026-07-01</dc:date>
      <dc:creator>Chen, Chian-Wei</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Evolving First-Line Endocrine Therapy in HR+/HER2− Metastatic Breast Cancer: CDK4/6 Inhibition, Biomarker-Guided Strategies and Emerging Therapeutic Paradigms.</title>
      <pubDate>Thu, 01 Jan 2026 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/195807453</link>
      <guid>https://descubridor.academia.cl/EITRecord/195807453</guid>
      <author>Abdel-Razeq, Hikmat</author>
      <dc:format>Journal Article</dc:format>
      <dc:date>2026-07-01</dc:date>
      <dc:creator>Abdel-Razeq, Hikmat</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Claudin 18.2 Expression and Outcomes of First-Line Chemoimmunotherapy in HER2-Negative Gastric or Gastroesophageal Junction Cancer: A Single-Center Retrospective Study.</title>
      <pubDate>Thu, 01 Jan 2026 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/196621287</link>
      <guid>https://descubridor.academia.cl/EITRecord/196621287</guid>
      <author>Bao, Run</author>
      <dc:format>Journal Article</dc:format>
      <dc:date>2026-08-01</dc:date>
      <dc:creator>Bao, Run</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>The Prognostic Significance of EGFR Adjusted Variant Allele Frequency on First-Line Osimertinib Efficacy in Advanced EGFR-Mutant NSCLC.</title>
      <pubDate>Thu, 01 Jan 2026 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/196621266</link>
      <guid>https://descubridor.academia.cl/EITRecord/196621266</guid>
      <author>Phillips, William J.</author>
      <dc:format>Journal Article</dc:format>
      <dc:date>2026-08-01</dc:date>
      <dc:creator>Phillips, William J.</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>First-Line Bruton's Tyrosine Kinase Inhibitor-Based Regimens for Mantle Cell Lymphoma.</title>
      <pubDate>Thu, 01 Jan 2026 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/195807458</link>
      <guid>https://descubridor.academia.cl/EITRecord/195807458</guid>
      <author>Puckrin, Robert</author>
      <dc:format>Journal Article</dc:format>
      <dc:date>2026-07-01</dc:date>
      <dc:creator>Puckrin, Robert</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Real-World Outcomes of First-Line Cetuximab and Platinum-Based Chemotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: A Multicenter Observational Study and Literature Review.</title>
      <pubDate>Thu, 01 Jan 2026 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/193441176</link>
      <guid>https://descubridor.academia.cl/EITRecord/193441176</guid>
      <author>Rakušić, Zoran</author>
      <dc:format>Journal Article</dc:format>
      <dc:date>2026-04-01</dc:date>
      <dc:creator>Rakušić, Zoran</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>"Trust, Responsibility, and Making a Difference": Qualitative Insights into Why First-Line Managers in Healthcare Remain in Their Role.</title>
      <pubDate>Tue, 01 Jan 0008 07:44:07 -0442</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/187508323</link>
      <guid>https://descubridor.academia.cl/EITRecord/187508323</guid>
      <author>Svanström, Jonas</author>
      <dc:format>research</dc:format>
      <dc:format>Journal Article</dc:format>
      <dc:date>2025-08-21</dc:date>
      <dc:creator>Svanström, Jonas</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Overcoming Acquired MET-Driven Resistance to First-Line Lorlatinib: Successful Combination of Lorlatinib and Envafolimab in an ALK-Positive NSCLC Patient with Ultra-High PD-L1 Expression.</title>
      <pubDate>Thu, 01 Jan 2026 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/194129130</link>
      <guid>https://descubridor.academia.cl/EITRecord/194129130</guid>
      <author>Ding, Lu</author>
      <dc:format>Journal Article</dc:format>
      <dc:date>2026-05-01</dc:date>
      <dc:creator>Ding, Lu</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>First-Line Pembrolizumab Monotherapy for Advanced Non-Small Cell Lung Cancer: A Multicenter Real-World Study from Vietnam.</title>
      <pubDate>Thu, 01 Jan 2026 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/193441208</link>
      <guid>https://descubridor.academia.cl/EITRecord/193441208</guid>
      <author>Pham, Thi Huong</author>
      <dc:format>Journal Article</dc:format>
      <dc:date>2026-04-01</dc:date>
      <dc:creator>Pham, Thi Huong</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Initial Low-Dose Dacomitinib for First-Line Treatment of Patients With EGFR Exon 21-Mutated Non-Small-Cell Lung Cancer.</title>
      <pubDate>Sat, 01 Jan 0005 07:44:07 -0442</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/194089746</link>
      <guid>https://descubridor.academia.cl/EITRecord/194089746</guid>
      <author>Liu, Ke-Jun</author>
      <dc:format>research</dc:format>
      <dc:format>tables/charts</dc:format>
      <dc:format>Journal Article</dc:format>
      <dc:date>2026-05-27</dc:date>
      <dc:creator>Liu, Ke-Jun</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Clinical Outcomes and Immune-Related Adverse Events in Metastatic Non-Squamous NSCLC Treated with First-Line Pembrolizumab–Chemotherapy: A Real-World Study from Serbia.</title>
      <pubDate>Thu, 01 Jan 2026 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/194129139</link>
      <guid>https://descubridor.academia.cl/EITRecord/194129139</guid>
      <author>Bojić, Zlatan</author>
      <dc:format>Journal Article</dc:format>
      <dc:date>2026-05-01</dc:date>
      <dc:creator>Bojić, Zlatan</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Real-World Utilization of Palbociclib as First-Line Treatment for Canadian HR+/HER2− Women with Metastatic Breast Cancer: Results from PALCAN Study.</title>
      <pubDate>Thu, 01 Jan 2026 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/191975506</link>
      <guid>https://descubridor.academia.cl/EITRecord/191975506</guid>
      <author>Rayson, Daniel</author>
      <dc:format>Journal Article</dc:format>
      <dc:date>2026-02-01</dc:date>
      <dc:creator>Rayson, Daniel</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Evidence-to-Decision Framework to Prioritize PD-1 and PD-L1 Immune Checkpoint Inhibitors for the WHO Model List of Essential Medicines to Treat Adults with Solid Tumors in the Palliative First-Line Setting: Pilot Study.</title>
      <pubDate>Thu, 01 Jan 2026 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/195521311</link>
      <guid>https://descubridor.academia.cl/EITRecord/195521311</guid>
      <author>Bartoszko, Jessica</author>
      <dc:format>research</dc:format>
      <dc:format>tables/charts</dc:format>
      <dc:format>Journal Article</dc:format>
      <dc:date>2026</dc:date>
      <dc:creator>Bartoszko, Jessica</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Comparative Efficacy and Safety of First-Line Immune Checkpoint Inhibitors Plus Chemotherapy with or Without Bevacizumab in Advanced Non-Squamous Non-Small Cell Lung Carcinoma.</title>
      <pubDate>Thu, 01 Jan 2026 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/192598828</link>
      <guid>https://descubridor.academia.cl/EITRecord/192598828</guid>
      <author>Chen, Ping</author>
      <dc:format>Journal Article</dc:format>
      <dc:date>2026-03-01</dc:date>
      <dc:creator>Chen, Ping</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>First-Line Modified FOLFIRINOX in Metastatic Pancreatic Cancer: Real-World Outcomes and Prognostic Factors From a Vietnamese Cohort.</title>
      <pubDate>Tue, 01 Jan 0002 07:44:07 -0442</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/191984260</link>
      <guid>https://descubridor.academia.cl/EITRecord/191984260</guid>
      <author>Nguyen, Huy Van</author>
      <dc:format>research</dc:format>
      <dc:format>tables/charts</dc:format>
      <dc:format>Journal Article</dc:format>
      <dc:date>2026-02-25</dc:date>
      <dc:creator>Nguyen, Huy Van</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Prognostic Value of Baseline Systemic Immune-Inflammation Index in Advanced Intrahepatic Cholangiocarcinoma Treated with First-Line Gemcitabine–Cisplatin Plus PD-L1 Inhibitor: A Single-Center Retrospective Study.</title>
      <pubDate>Thu, 01 Jan 2026 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/191975548</link>
      <guid>https://descubridor.academia.cl/EITRecord/191975548</guid>
      <author>Wu, Shuan</author>
      <dc:format>Journal Article</dc:format>
      <dc:date>2026-02-01</dc:date>
      <dc:creator>Wu, Shuan</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>A Podcast on Real-World Evidence with Avelumab First-Line Maintenance and Treatment Sequencing in Locally Advanced or Metastatic Urothelial Carcinoma.</title>
      <pubDate>Wed, 01 Jan 2025 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/188149024</link>
      <guid>https://descubridor.academia.cl/EITRecord/188149024</guid>
      <author>Grivas, Petros</author>
      <dc:format>Journal Article</dc:format>
      <dc:date>2025-09-01</dc:date>
      <dc:creator>Grivas, Petros</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Expanded span of control, leadership and management performance, work-related stress, and job satisfaction among first-line managers: A repeated cross-sectional study.</title>
      <pubDate>Wed, 01 Jan 2025 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/186103423</link>
      <guid>https://descubridor.academia.cl/EITRecord/186103423</guid>
      <author>Svanström, Jonas</author>
      <dc:format>research</dc:format>
      <dc:format>tables/charts</dc:format>
      <dc:format>Journal Article</dc:format>
      <dc:date>2025-07-01</dc:date>
      <dc:creator>Svanström, Jonas</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Real‐World Practice Patterns in Diagnosis and First‐Line Treatment in Metastatic Breast Cancer.</title>
      <pubDate>Sun, 01 Jan 0006 07:44:07 -0442</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/194947009</link>
      <guid>https://descubridor.academia.cl/EITRecord/194947009</guid>
      <author>Manohar, Poorni M.</author>
      <dc:format>research</dc:format>
      <dc:format>tables/charts</dc:format>
      <dc:format>Journal Article</dc:format>
      <dc:date>2026-06-28</dc:date>
      <dc:creator>Manohar, Poorni M.</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>18F-fluoroestradiol (18F-FES) PET/CT for guiding first-line treatment in patients with HR + /HER2- metastatic breast cancer: impact on progression free survival.</title>
      <pubDate>Wed, 01 Jan 2025 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/189634285</link>
      <guid>https://descubridor.academia.cl/EITRecord/189634285</guid>
      <author>Xie, Yizhao</author>
      <dc:format>Journal Article</dc:format>
      <dc:date>2025-12-01</dc:date>
      <dc:creator>Xie, Yizhao</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Comparison of the Efficacy of First-Line Pemetrexed-Platinum and Gemcitabine-Platinum Regimens in Malignant Peritoneal Mesothelioma.</title>
      <pubDate>Fri, 01 Jan 0010 07:44:07 -0442</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/188898019</link>
      <guid>https://descubridor.academia.cl/EITRecord/188898019</guid>
      <author>Bayram, Doğan</author>
      <dc:format>research</dc:format>
      <dc:format>tables/charts</dc:format>
      <dc:format>Journal Article</dc:format>
      <dc:date>2025-10-17</dc:date>
      <dc:creator>Bayram, Doğan</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Immune-Related Thyroid Dysfunction in PD-L1 High Non-Oncogene-Addicted NSCLC Treated with First-Line Pembrolizumab: Incidence, Timing, and Predictive Impact.</title>
      <pubDate>Thu, 01 Jan 2026 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/191975534</link>
      <guid>https://descubridor.academia.cl/EITRecord/191975534</guid>
      <author>Marković, Filip</author>
      <dc:format>Journal Article</dc:format>
      <dc:date>2026-02-01</dc:date>
      <dc:creator>Marković, Filip</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Correspondence on: "Real-world safety data of first-line drugs for rheumatoid arthritis: insights from the Portuguese Reuma.pt database".</title>
      <pubDate>Thu, 01 Jan 2026 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/195258517</link>
      <guid>https://descubridor.academia.cl/EITRecord/195258517</guid>
      <author>Choudhuri, B.</author>
      <dc:format>Artículo</dc:format>
      <dc:date>2026</dc:date>
      <dc:creator>Choudhuri, B.</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>[18F]Fluorocholine PET/MRI and [18F]Fluorocholine PET/CT as first- and second-line imaging in primary hyperparathyroidism – who takes the lead?</title>
      <pubDate>Wed, 01 Jan 2025 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/189136484</link>
      <guid>https://descubridor.academia.cl/EITRecord/189136484</guid>
      <author>Petranović Ovčariček, Petra</author>
      <dc:format>Journal Article</dc:format>
      <dc:date>2025-11-01</dc:date>
      <dc:creator>Petranović Ovčariček, Petra</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Study of Low-Risk GTN Patients Resistant to First-Line Chemotherapy with MTX in a Tertiary Hospital Center.</title>
      <pubDate>Wed, 01 Jan 2025 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/188604570</link>
      <guid>https://descubridor.academia.cl/EITRecord/188604570</guid>
      <author>Farazestanian, Marjaneh</author>
      <dc:format>research</dc:format>
      <dc:format>tables/charts</dc:format>
      <dc:format>Journal Article</dc:format>
      <dc:date>2025-10-01</dc:date>
      <dc:creator>Farazestanian, Marjaneh</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>A Multicenter Retrospective Study of Avelumab First-Line Maintenance and Subsequent Therapies for Locally Advanced and Metastatic Urothelial Carcinoma: Subgroup Analysis of First-Line Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, and Gemcitabine Plus Cisplatin in the Japan AVElumab MAintenance and Continuous Treatment Study (JAVEMACS)</title>
      <pubDate>Wed, 01 Jan 2025 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/189611401</link>
      <guid>https://descubridor.academia.cl/EITRecord/189611401</guid>
      <author>Ikeda, Masaomi</author>
      <dc:format>Journal Article</dc:format>
      <dc:date>2025-11-01</dc:date>
      <dc:creator>Ikeda, Masaomi</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Docetaxel and Ramucirumab as Subsequent Treatment After First-Line Immunotherapy-Based Treatment for Metastatic Non-Small-Cell Lung Cancer: A Retrospective Study and Literature Review.</title>
      <pubDate>Wed, 01 Jan 2025 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/189611395</link>
      <guid>https://descubridor.academia.cl/EITRecord/189611395</guid>
      <author>Loizidis, Sotiris</author>
      <dc:format>Journal Article</dc:format>
      <dc:date>2025-11-01</dc:date>
      <dc:creator>Loizidis, Sotiris</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Contemporary Fixed-Duration Treatment Options in the First-Line Setting of Chronic Lymphocytic Leukemia: Perspectives from a Publicly Funded Healthcare System.</title>
      <pubDate>Wed, 01 Jan 2025 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/188957449</link>
      <guid>https://descubridor.academia.cl/EITRecord/188957449</guid>
      <author>Lemieux, Christopher</author>
      <dc:format>Journal Article</dc:format>
      <dc:date>2025-10-01</dc:date>
      <dc:creator>Lemieux, Christopher</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Efficacy and Safety of First-Line Chemotherapy-Based Combination Therapy for Patients With Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis.</title>
      <pubDate>Tue, 01 Jan 0008 07:44:07 -0442</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/190387874</link>
      <guid>https://descubridor.academia.cl/EITRecord/190387874</guid>
      <author>Zhao, Qingfang</author>
      <dc:format>meta analysis</dc:format>
      <dc:format>research</dc:format>
      <dc:format>systematic review</dc:format>
      <dc:format>tables/charts</dc:format>
      <dc:format>Journal Article</dc:format>
      <dc:date>2025-08-28</dc:date>
      <dc:creator>Zhao, Qingfang</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Real-world safety data of first-line drugs for rheumatoid arthritis: insights from the Portuguese Reuma.pt database.</title>
      <pubDate>Wed, 01 Jan 2025 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/190727923</link>
      <guid>https://descubridor.academia.cl/EITRecord/190727923</guid>
      <author>Ramos Rodrigues, J.</author>
      <dc:format>Artículo</dc:format>
      <dc:date>2025</dc:date>
      <dc:creator>Ramos Rodrigues, J.</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Real-World Retrospective Study of Clinical and Economic Outcomes Among Patients with Locally Advanced or Metastatic Urothelial Carcinoma Treated with First-Line Systemic Anti-Cancer Therapies in the United States: Results from the IMPACT UC-III Study.</title>
      <pubDate>Wed, 01 Jan 2025 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/186934649</link>
      <guid>https://descubridor.academia.cl/EITRecord/186934649</guid>
      <author>Moon, Helen H.</author>
      <dc:format>Journal Article</dc:format>
      <dc:date>2025-07-01</dc:date>
      <dc:creator>Moon, Helen H.</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Bridging Strategy and Local Reality: First-Line Managers' Experiences in Leading Large-Scale Implementation.</title>
      <pubDate>Tue, 01 Jan 0002 07:44:07 -0442</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/191833485</link>
      <guid>https://descubridor.academia.cl/EITRecord/191833485</guid>
      <author>Viktorsson, Lisa</author>
      <dc:format>research</dc:format>
      <dc:format>tables/charts</dc:format>
      <dc:format>Journal Article</dc:format>
      <dc:date>2026-02-23</dc:date>
      <dc:creator>Viktorsson, Lisa</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Eculizumab as first-line treatment for patients with severe presentation of complement factor H antibody–mediated hemolytic uremic syndrome.</title>
      <pubDate>Wed, 01 Jan 2025 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/183485106</link>
      <guid>https://descubridor.academia.cl/EITRecord/183485106</guid>
      <author>Coccia, Paula A.</author>
      <dc:format>case study</dc:format>
      <dc:format>research</dc:format>
      <dc:format>tables/charts</dc:format>
      <dc:format>Journal Article</dc:format>
      <dc:date>2025-04-01</dc:date>
      <dc:creator>Coccia, Paula A.</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Person-centred leadership in residential care for older people as described by first-line managers.</title>
      <pubDate>Sun, 01 Jan 0006 07:44:07 -0442</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/186108032</link>
      <guid>https://descubridor.academia.cl/EITRecord/186108032</guid>
      <author>Jönsson, Marie</author>
      <dc:format>research</dc:format>
      <dc:format>tables/charts</dc:format>
      <dc:format>Journal Article</dc:format>
      <dc:date>2025-06-23</dc:date>
      <dc:creator>Jönsson, Marie</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Comparing the Effectiveness and Safety of Intravenous Levetiracetam and Phenobarbital as First-Line Therapies for Neonatal Seizures: A Randomized Clinical Trial.</title>
      <pubDate>Wed, 01 Jan 2025 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/184199760</link>
      <guid>https://descubridor.academia.cl/EITRecord/184199760</guid>
      <author>Khosroshahi, Nahideh</author>
      <dc:format>research</dc:format>
      <dc:format>tables/charts</dc:format>
      <dc:format>randomized controlled trial</dc:format>
      <dc:format>Journal Article</dc:format>
      <dc:date>2025</dc:date>
      <dc:creator>Khosroshahi, Nahideh</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Real-world results of first-line ABVD in patients with classic Hodgkin's lymphoma at a neoplastic disease institute in Lima, Peru.</title>
      <pubDate>Wed, 01 Jan 2025 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/190640091</link>
      <guid>https://descubridor.academia.cl/EITRecord/190640091</guid>
      <author>Salinas Agramonte, Luis</author>
      <dc:format>Artículo</dc:format>
      <dc:date>2025</dc:date>
      <dc:creator>Salinas Agramonte, Luis</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>High-Throughput Hybridization Assay as First-Line Diagnostic Test for Sarcomas: Clinical Assessment in a Tertiary Referral Center.</title>
      <pubDate>Wed, 01 Jan 2025 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/185710496</link>
      <guid>https://descubridor.academia.cl/EITRecord/185710496</guid>
      <author>Salguero-Aranda, Carmen</author>
      <dc:format>research</dc:format>
      <dc:format>tables/charts</dc:format>
      <dc:format>Journal Article</dc:format>
      <dc:date>2025-06-01</dc:date>
      <dc:creator>Salguero-Aranda, Carmen</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>First‐line managers´ perceptions of missed nursing care in community health care for older people–A phenomenographic study.</title>
      <pubDate>Mon, 01 Jan 2024 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/180951755</link>
      <guid>https://descubridor.academia.cl/EITRecord/180951755</guid>
      <author>Andersson, Ingrid</author>
      <dc:format>research</dc:format>
      <dc:format>tables/charts</dc:format>
      <dc:format>Journal Article</dc:format>
      <dc:date>2024-12-01</dc:date>
      <dc:creator>Andersson, Ingrid</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Radiotherapy combined with chemoimmunotherapy improves survival compared to chemoimmunotherapy alone as first-line treatment for oligometastatic esophageal squamous cell carcinoma.</title>
      <pubDate>Wed, 01 Jan 2025 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/188453208</link>
      <guid>https://descubridor.academia.cl/EITRecord/188453208</guid>
      <author>Lv, Xiaoyan</author>
      <dc:format>Journal Article</dc:format>
      <dc:date>2025-10-01</dc:date>
      <dc:creator>Lv, Xiaoyan</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>First‐Line Marshall Plan Approach in Persistent Atrial Fibrillation: A Prospective Single‐Center Cohort Study.</title>
      <pubDate>Wed, 01 Jan 2025 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/186460406</link>
      <guid>https://descubridor.academia.cl/EITRecord/186460406</guid>
      <author>Carmaux, Antoine</author>
      <dc:format>research</dc:format>
      <dc:format>tables/charts</dc:format>
      <dc:format>Journal Article</dc:format>
      <dc:date>2025-06-01</dc:date>
      <dc:creator>Carmaux, Antoine</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Lutetium-177 PSMA radioligand therapy in taxan-naive first- and second-line metastatic castration resistant prostate cancer after first-line ARPI therapy.</title>
      <pubDate>Wed, 01 Jan 2025 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/184671083</link>
      <guid>https://descubridor.academia.cl/EITRecord/184671083</guid>
      <author>Wenzel, Mike</author>
      <dc:format>Journal Article</dc:format>
      <dc:date>2025-05-01</dc:date>
      <dc:creator>Wenzel, Mike</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Real-World Clinical Outcomes with First-Line Systemic Treatment and Avelumab Maintenance in US Patients with Locally Advanced or Metastatic Urothelial Carcinoma: The SPEAR Bladder-II Study.</title>
      <pubDate>Wed, 01 Jan 2025 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/184749578</link>
      <guid>https://descubridor.academia.cl/EITRecord/184749578</guid>
      <author>Sura, Sneha</author>
      <dc:format>Journal Article</dc:format>
      <dc:date>2025-04-01</dc:date>
      <dc:creator>Sura, Sneha</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Should transjugular intrahepatic portosystemic shunt be first-line therapy for preventing esophageal variceal rebleeding? A meta-analysis of clinical outcomes.</title>
      <pubDate>Wed, 01 Jan 2025 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/187310964</link>
      <guid>https://descubridor.academia.cl/EITRecord/187310964</guid>
      <author>Kareem, Rutaab</author>
      <dc:format>meta analysis</dc:format>
      <dc:format>research</dc:format>
      <dc:format>systematic review</dc:format>
      <dc:format>tables/charts</dc:format>
      <dc:format>Journal Article</dc:format>
      <dc:date>2025-09-01</dc:date>
      <dc:creator>Kareem, Rutaab</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Direct aspiration versus stent retriever as First-line thrombectomy techniques for acute Basilar artery occlusions: an updated systematic review and Meta-Analysis.</title>
      <pubDate>Wed, 01 Jan 2025 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/189357981</link>
      <guid>https://descubridor.academia.cl/EITRecord/189357981</guid>
      <author>Lee, Wei Jun</author>
      <dc:format>meta analysis</dc:format>
      <dc:format>research</dc:format>
      <dc:format>systematic review</dc:format>
      <dc:format>tables/charts</dc:format>
      <dc:format>Journal Article</dc:format>
      <dc:date>2025-10-01</dc:date>
      <dc:creator>Lee, Wei Jun</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Quantitative evaluation of the efficacy and safety of first-line systemic therapies for advanced hepatocellular carcinoma.</title>
      <pubDate>Wed, 01 Jan 2025 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/183079875</link>
      <guid>https://descubridor.academia.cl/EITRecord/183079875</guid>
      <author>Wang, Xinrui</author>
      <dc:format>research</dc:format>
      <dc:format>tables/charts</dc:format>
      <dc:format>Journal Article</dc:format>
      <dc:date>2025-03-01</dc:date>
      <dc:creator>Wang, Xinrui</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Real-World Treatment Patterns, Healthcare Resource Utilization, and Healthcare Costs in the First-Line Treatment of Metastatic Non-Small Cell Lung Cancer in the US.</title>
      <pubDate>Wed, 01 Jan 2025 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/184100049</link>
      <guid>https://descubridor.academia.cl/EITRecord/184100049</guid>
      <author>Chopra, Divyan</author>
      <dc:format>Journal Article</dc:format>
      <dc:date>2025-03-01</dc:date>
      <dc:creator>Chopra, Divyan</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Association Between Sarcopenia, Clinical Outcomes, and Survival in Patients with Extensive-Stage Small Cell Lung Cancer Treated with First-Line Immunochemotherapy: A Prospective Cohort Study.</title>
      <pubDate>Wed, 01 Jan 2025 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/181109382</link>
      <guid>https://descubridor.academia.cl/EITRecord/181109382</guid>
      <author>Tian, Le</author>
      <dc:format>research</dc:format>
      <dc:format>tables/charts</dc:format>
      <dc:format>Journal Article</dc:format>
      <dc:date>2025</dc:date>
      <dc:creator>Tian, Le</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Longitudinal Adherence Trajectories of First-Line Nucleotide Analogues among US Older Adults with Chronic Hepatitis B.</title>
      <pubDate>Thu, 01 Jan 2026 07:44:07 -0300</pubDate>
      <link>https://descubridor.academia.cl/EITRecord/196735367</link>
      <guid>https://descubridor.academia.cl/EITRecord/196735367</guid>
      <author>Khalid, Javeria</author>
      <dc:format>Journal Article</dc:format>
      <dc:date>2026-09-01</dc:date>
      <dc:creator>Khalid, Javeria</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
  </channel>
</rss>
Cannot write session to /tmp/vufind_sessions/sess_sf8csjp2hi7pduea3vj88m2g7q
